Optos, the company behind the Optomap retinal exam system, will float on the London stock exchange next month valued at an estimated £150m.
Optos, the company behind the Optomap retinal exam system, will float on the London stock exchange next month valued at an estimated £150m.
The Dunfermline company plans to raise funds to expand in overseas markets, according to The Scotsman.
Company founder Douglas Anderson (pictured) invented the imaging technology after opticians failed to spot signs of a detached retina in the eye of his son, Leif.
Analysts estimate the global demand for the machine could top £1bn, and Optos aims to capture the entire market.
Read the full story in Friday's Optician.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here